Related Experiment Videos
Summary
Patients with portal hypertension exhibit significantly lower plasma fibronectin levels. This reduction in fibronectin may be due to increased consumption by an enlarged spleen in these individuals.
Area of Science:
- Hepatology
- Biochemistry
Background:
- Portal hypertension is a serious complication of chronic liver disease.
- Fibronectin is a glycoprotein involved in various biological processes, including coagulation and cell adhesion.
Purpose of the Study:
- To investigate plasma fibronectin levels in patients with portal hypertension.
- To explore the relationship between fibronectin levels, portal hypertension, and splenomegaly.
Main Methods:
- Plasma fibronectin levels were measured in patients with chronic liver disease, non-cirrhotic portal hypertension, and those who underwent shunt surgery.
- Statistical analysis was performed to compare fibronectin levels between groups.
Main Results:
- Patients with portal hypertension showed significantly lower plasma fibronectin levels (207 +/- 54) compared to those without portal hypertension (315 +/- 75).
- Patients who underwent shunt surgery and splenectomy had normalized fibronectin levels (330 +/- 66).
Conclusions:
- Low plasma fibronectin levels are associated with portal hypertension.
- Increased consumption of fibronectin by an enlarged spleen may explain the reduced levels in portal hypertension.